Rare Epilepsy Updates: One New Drug, Two Clinical Trials, and Orphan Drug Designation
A recent article published in Globe Newswire heralded Marinus Pharmaceuticals’ new drug, ganaxolone. The drug has been studied in over 1600 patients and is now being tested in two clinical…